Biotechnology, Life Sciences and Pharmaceutical Articles
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board… Continue Reading →
Genmab Partners with The Chase Group to Build Their Translational Research Team
Genmab has once again retained The Chase Group with a new request to assist with the continued growth of their Translational Research team. The Chase… Continue Reading →
Ionis Pharmaceuticals Continues to Cut to the Chase
Ionis Pharmaceuticals continues to partner with The Chase Group to find high caliber talent to join them in revolutionizing medicine through the discovery and development… Continue Reading →
Ipsen US Retains The Chase Group to Recruit a Vice President, Neurology Franchise Head
With the relocation of their headquarters to Cambridge, MA, Ipsen US is entering a new era of innovation and growth to become a leading global… Continue Reading →
Marinus Pharmaceuticals Retains The Chase Group for Multiple Positions
Marinus Pharmaceuticals once again turns to The Chase Group for their expertise and experience in life science executive search to assist them in finding exceptional… Continue Reading →Another Successful Placement by The Chase Group at Marinus Pharmaceuticals
The Chase Group is pleased to announce the successful completion of the Executive Director, Head of Clinical Development Operations search at Marinus Pharmaceuticals. The successful… Continue Reading →The Chase Group Successfully Completes Vice President, Clinical Development, Respiratory for Ionis Pharmaceuticals
The Chase Group appreciates and values our continued partnership with Ionis Pharmaceuticals and is pleased to announce the successful completion of the Vice President, Clinical… Continue Reading →
Another Key Placement by The Chase Group
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer. We are so proud to connect life-changing executives and companies! Continue Reading →